Cite
HARVARD Citation
Gross, Z. et al. (2018). Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study. European journal of haematology. pp. 621-623. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gross, Z. et al. (2018). Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study. European journal of haematology. pp. 621-623. [Online].